DUSA Pharmaceuticals Reports First Quarter 2012 Corporate Highlights and Financial Results
May 08, 2012 06:30 ET
|
DUSA Pharmaceuticals, Inc.
Q1 Domestic PDT Revenues Up 26% Year-Over-Year; Company Achieves Record Domestic BLU-U® Sales Volumes
Conference Call and Audio Webcast Will Be Held Today, May 8th, at 8:30am...
DUSA Pharmaceuticals, Inc.(R) to Host First Quarter 2012 Corporate Highlights and Financial Results Webcast and Conference Call
May 01, 2012 06:30 ET
|
DUSA Pharmaceuticals, Inc.
WILMINGTON, Mass., May 1, 2012 (GLOBE NEWSWIRE) -- DUSA Pharmaceuticals, Inc. (Nasdaq:DUSA) announces that its first quarter 2012 corporate highlights and financial results press release will be...
DUSA Pharmaceuticals Completes Enrollment in Phase 2 Studies of Levulan(R) Kerastick(R) Photodynamic Therapy
April 24, 2012 07:30 ET
|
DUSA Pharmaceuticals, Inc.
WILMINGTON, Mass., April 24, 2012 (GLOBE NEWSWIRE) -- DUSA Pharmaceuticals, Inc.® (Nasdaq:DUSA), a dermatology company that is developing and marketing its Levulan® Photodynamic Therapy...
DUSA Pharmaceuticals Introduces Teeing Off Against Sun Damage(TM) Campaign to Raise Awareness of Actinic Keratosis
April 10, 2012 08:30 ET
|
DUSA Pharmaceuticals, Inc.
WILMINGTON, Mass., April 10, 2012 (GLOBE NEWSWIRE) -- Dermatology company DUSA Pharmaceuticals, Inc.® (Nasdaq:DUSA), today introduced its Teeing Off Against Sun Damage™ campaign. This...
DUSA Pharmaceuticals to Present at the 2012 Maxim Group Growth Conference
March 23, 2012 08:00 ET
|
DUSA Pharmaceuticals, Inc.
WILMINGTON, Mass., March 23, 2012 (GLOBE NEWSWIRE) -- DUSA Pharmaceuticals, Inc.® (Nasdaq:DUSA), a dermatology company that is developing and marketing Levulan® Photodynamic Therapy (PDT),...
DUSA Pharmaceuticals to Present at the 2012 Maxim Group Growth Conference
March 19, 2012 08:30 ET
|
DUSA Pharmaceuticals, Inc.
WILMINGTON, Mass., March 19, 2012 (GLOBE NEWSWIRE) -- DUSA Pharmaceuticals, Inc.® (Nasdaq:DUSA), a dermatology company that is developing and marketing Levulan® Photodynamic Therapy (PDT),...
DUSA Pharmaceuticals Introduces "Spot Signs of AK" Campaign to Raise Awareness of a Common Precancerous Skin Condition - Actinic Keratosis
March 16, 2012 09:00 ET
|
DUSA Pharmaceuticals, Inc.
Campaign and New Website www.spotsignsofAK.com Launched Today During American Academy of Dermatology Annual Meeting
WILMINGTON, Mass., March 16, 2012 (GLOBE NEWSWIRE) -- Dermatology company DUSA...
DUSA Pharmaceuticals to Present at Roth Capital Partners 24th Annual OC Growth Stock Conference
March 07, 2012 08:30 ET
|
DUSA Pharmaceuticals, Inc.
WILMINGTON, Mass., March 7, 2012 (GLOBE NEWSWIRE) -- DUSA Pharmaceuticals, Inc.® (Nasdaq:DUSA), a dermatology company that is developing and marketing Levulan® Photodynamic Therapy (PDT),...
DUSA Pharmaceuticals Reports Full Year 2011 Corporate Highlights and Financial Results
March 06, 2012 06:30 ET
|
DUSA Pharmaceuticals, Inc.
Record Fourth Quarter Revenues Drive Significant Income and Cash Flow Improvements Year-Over-Year
Fourth Quarter Highlighted by 30% Domestic Kerastick® Revenue Growth
Conference Call and...
DUSA Pharmaceuticals, Inc.(R) to Host Fourth Quarter and Full Year 2011 Corporate Highlights and Financial Results Conference Call
February 28, 2012 06:30 ET
|
DUSA Pharmaceuticals, Inc.
WILMINGTON, Mass., Feb. 28, 2012 (GLOBE NEWSWIRE) -- DUSA Pharmaceuticals, Inc. (Nasdaq:DUSA) announces that its fourth quarter and full year 2011 corporate highlights and financial results press...